Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: BOSTONGENE CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-09-16 to 2025-09-15
Current total value of award: $302039.2
Description: DEEP SEQUENCING ANALYSIS SERVICES TO MONITOR COPANLISIB/RITUXIMAB COMBINATION TREATMENT